IDA blend vs Japan: Cause of death, by non-communicable diseases, ages 5-14
IDA blend
24.2%
in 2021
Japan
61.0%
in 2021
IDA blend rank
30th
Japan rank
30th
Cause of death, by non-communicable diseases, ages 5-14 over time
- IDA blend
- Japan
How they compare
Japan currently reports 61.0% against 24.2% in IDA blend, a difference of 36.8%.
That makes Japan's figure about 2.5 times IDA blend's.
Across all 6 years both countries report, Japan has been ahead every year.
IDA blend ranks 30th and Japan ranks 30th of 47 groups.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.2% | 52.4% | 40.3% | Japan |
| 2010s | 18.7% | 58.2% | 39.5% | Japan |
| 2020s | 23.2% | 59.0% | 35.8% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, IDA blend or Japan?
- Japan, at 61.0% against 24.2% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between IDA blend and Japan?
- 36.8%, with Japan ahead.
- How many years of comparable data are there for IDA blend and Japan?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA blend and Japan rank globally for cause of death, by non-communicable diseases, ages 5-14?
- IDA blend ranks 30th and Japan ranks 30th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.